Skip to main content
Clinical Trials/JPRN-UMIN000002782
JPRN-UMIN000002782
Completed
未知

A Randomized controlled study to evaluate the efficacy on male lower urinary tract symptoms with overactive bladder of alpha 1-adrenoceptor antagonist in monotherapy and combination therapy with Eviprostat - A Randomized controlled study to evaluate the efficacy on male lower urinary tract symptoms with overactive bladder of alpha 1-adrenoceptor antagonist in monotherapy and combination therapy with Eviprostat

Oita University Faculty of Medicine,Department of Urology0 sites120 target enrollmentDecember 25, 2009

Overview

Phase
未知
Intervention
Not specified
Conditions
Male lower urinary tract symptoms with overactive bladder
Sponsor
Oita University Faculty of Medicine,Department of Urology
Enrollment
120
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 25, 2009
End Date
December 1, 2011
Last Updated
2 years ago
Study Type
Interventional
Sex
Male

Investigators

Sponsor
Oita University Faculty of Medicine,Department of Urology

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Patients taking medications considered likely to affect micturition 2\. PSA\>10ng/ml, Patients who suspected prostate cancer 3\. Patients who suspected neurogenic bladder 4\. Patients with urethral stricture 5\. Patients with chronic prostatitis or active urinary tract infenction 6\. Patients with previous surgery for BPH 7\.Patients with previous intrapelvic radiation 8\. Complications considered likely to affect micturition(bladder neck constriction,bladder calculus,urinary calculus, cerebrovascular disease etc). 9\. Patients with severe hepatic disorders,severe renal dysfunction and severe cardiovascular disease 10\. Patients with performing intermittent catheter insertion themselves 11\. Patients with orthostatic hypotension 12\.Patients taking OTC medication and dietary supplement considered likely to affect micturition

Outcomes

Primary Outcomes

Not specified

Similar Trials